<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02828085</url>
  </required_header>
  <id_info>
    <org_study_id>2013-30</org_study_id>
    <secondary_id>2013-A00962-43</secondary_id>
    <nct_id>NCT02828085</nct_id>
  </id_info>
  <brief_title>Improvement of the Etiological Diagnosis of the Pericarditis</brief_title>
  <acronym>PERICARDITE</acronym>
  <official_title>Improvement of the Etiological Diagnosis of the Pericarditis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <brief_summary>
    <textblock>
      Pericardial syndrome includes pericardites acute pericardial effusion and cardiac tamponade,
      recurrent pericarditis squeezing chronic pericarditis. The etiologies are very numerous and
      can be classified as infectious, neoplastic, metabolic or systemic, toxic causes. Diagnosis
      is difficult, and 80% of etiologies remain classified idiopathic. In their laboratory to
      improve the diagnosis of this syndrome investigators have developed a strategy of systematic
      prescription of biological tests by kit. This prescription by 'kit' strategy proved its
      interest by comparison with an intuitive requirement of biological. In this study
      investigators want to improve the diagnostic causative of pericarditis by implementing a new
      diagnostic strategy. This new strategy includes (i) samples additional less invasive for the
      patient, the swab pharyngeal and nasal, (ii) the addition of at the outset of more effective
      diagnostic techniques: specific Polymerase Chain Reaction (PCR)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of pericarditis whose etiological diagnosis has been established.</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identification of the detected emerging pathogens among infectious causesof pericarditis</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of the emerging pathogens: assessement of the percentage of emerging pathogens among the studied population</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Infective Pericarditis</condition>
  <arm_group>
    <arm_group_label>Infective Pericarditis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>In patient prescribed with a pericardite kit for an etiological diagnosis of a pericardial syndrome, an additional nasal swab will be performed in order to perform a specific diagnosis with PCR technique.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Nasal swab</intervention_name>
    <description>Nasal swab will be performed in addition to the routine diagnosis visit in order to determine the diagnosis of infective pericardite with a more specific technique: PCR</description>
    <arm_group_label>Infective Pericarditis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient prescribed with a pericarditis kit for etiological diagnosis of a pericardial
             syndrome.

          -  Adult patient (= or &gt; 18 years old)

          -  Patient who freely signed the informed consent form.

          -  Patient affiliated to a health insurance regime

        Exclusion Criteria:

          -  Minor patient ( age &lt;18 years)

          -  Pregnant, parturient or breastfeeding woman

          -  Adult patient incapable or unable to consent

          -  Patient deprived of liberty under judgment

          -  Person living in a health or social specialised structure

          -  Person in vital emergency situation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Frederique Gouriet, Dr</last_name>
    <phone>04 91 38 55 14</phone>
    <phone_ext>+33</phone_ext>
    <email>frederique.gouriet@ap-hm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexandra Giuliani</last_name>
    <phone>04 91 38 28 70</phone>
    <phone_ext>+33</phone_ext>
    <email>alexandra.giuliani@ap-hm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederique Gouriet, Dr</last_name>
      <phone>04 91 38 55 14</phone>
      <email>frederique.gouriet@ap-hm.fr</email>
    </contact>
    <contact_backup>
      <last_name>Alexandra Giuliani</last_name>
      <phone>04 91 38 28 70</phone>
      <phone_ext>+33</phone_ext>
      <email>alexandra.giuliani@ap-hm.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2016</study_first_submitted>
  <study_first_submitted_qc>July 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2016</study_first_posted>
  <last_update_submitted>July 6, 2016</last_update_submitted>
  <last_update_submitted_qc>July 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pericarditis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

